Patients with psoriasis present reduced levels and efflux capacity of HDL-C, increased LDL-C particle concentration and decreased LDL-C size, as well as elevated levels of circulating PCSK9 when compared to non-psoriasis individuals (31–33). Here, PCSK9 is linked to psoriasis.